Resilience Capital Partners announced that it has been named one of the Top 50 Middle Market Private Equity Firms for the second year in a row, the latest in a series of honors the firm has garnered as it has successfully transformed companies in the U.S. and globally.

Resilience also completed one of its most active years ever in 2017, acquiring or establishing controlling investments in six companies, including three new platforms, with investments in businesses that have substantial operations on three continents.

“Ranking among the Top 50 Middle Market Private Equity Firms for the second consecutive year shows that industry observers recognize our accomplishments in transforming and growing companies, making them more competitive and generating value for investors,” said Steven H. Rosen, co-CEO of Resilience Capital Partners. “I want to thank our team members here at Resilience and our partners in our portfolio companies, whose hard work is the foundation of our success, as well as our global limited partners.”

Resilience was named one of the 2018 Top 50 Middle Market Private Equity Firms by Bauer Rock Media Group, publisher of M&A Chicago, SBIC Weekly and Dealmaker South, and Grady Campbell Inc.

Among other honors during the year, Healthcare Business News ranked Resilience’s purchase of Bayer’s Multi Vendor Service business as one of the top five acquisitions of 2017.

The honors come after a dynamic 2017. “During 2017, we invested in industries as different as medical device repair, digital and print marketing and packaging and labeling. We also invested in companies with operations not only in the U.S. but also the United Kingdom, Mexico, Singapore, China, Thailand and Indonesia,” said Bassem A. Mansour, the co-CEO of the Cleveland-based firm. “The growing breadth of industries in which we participate, and the increased diversity of geographies in which our portfolio companies operate, positions us to succeed in any type of economy.”

All of Resilience’s investments during 2017 were funded through Resilience Fund IV, a $350 million fund.